首页> 外文期刊>Allergy >Serum-induced basophil CD63 expression by means of a tricolour flow cytometric method for the in vitro diagnosis of chronic urticaria.
【24h】

Serum-induced basophil CD63 expression by means of a tricolour flow cytometric method for the in vitro diagnosis of chronic urticaria.

机译:血清诱导的嗜碱性粒细胞CD63表达的三色流式细胞术方法在体外诊断为慢性荨麻疹。

获取原文
获取原文并翻译 | 示例
           

摘要

Functional autoantibodies against the alpha-chain of the high-affinity IgE receptor (FcepsilonRIalpha) identify a subset of patients with chronic urticaria (CU) due to autoreactivity, as assessed by an in vivo positive response to autologous serum skin test (ASST). We performed a study to standardize the serum-induced basophil activation assay by flow cytometry (FCM) using a new tricolour method, assessing the diagnostic performance of this test in discriminating between ASST+ and ASST- CU patients. Sera of 64 CU patients (22 ASST+ CU and 42 ASST- CU) and 10 healthy subjects were tested for their ability to induce basophil CD63 expression when incubated with whole blood of both atopic (D(A)) and non-atopic donors (D(NA)). Using a triple-labelled strategy with anti-CD123, anti-HLA-DR and anti-CD63 antibodies, CD63+ basophils were identified on a selected population of CD123+ HLA-DR- cells. In 3 ASST+ CU patients who underwent cyclosporine therapy, the assay was performed before and after treatment. The ASST+ CU sera resulted in a significant higher induction of basophil CD63 expression compared with ASST- CU and healthy donors sera; when whole blood from D(A) was used, sensitivity and specificity of the assay were 95.5% and 90.5% respectively. ASST+ CU serum activity was significantly decreased during cyclosporine A treatment, in parallel with clinical remission. Chronic urticaria serum-induced CD63 expression assay performed on D(A) whole blood by means of our tricolour FCM method could be the most useful tool for identification of a subset of patients with autoimmune CU and may become a promising tool also for monitoring treatment efficacy.
机译:根据对自体血清皮肤测试(ASST)的体内阳性反应评估,针对高亲和力IgE受体(FcepsilonRIalpha)的α链的功能性自身抗体可识别出一部分因自身反应性而患有慢性荨麻疹(CU)的患者。我们进行了一项研究,以使用新的三色方法通过流式细胞术(FCM)标准化血清诱导的嗜碱性粒细胞激活测定,评估了该测试在区分ASST +和ASST-CU患者中的诊断性能。测试了64名CU患者(22名ASST + CU和42名ASST-CU)和10名健康受试者的血清与特应性(D(A))和非特应性供体(D(D))的全血一起孵育时诱导嗜碱性粒细胞CD63表达的能力。 (NA))。使用具有抗CD123,抗HLA-DR和抗CD63抗体的三重标记策略,在选定的CD123 + HLA-DR-细胞群体中鉴定出CD63 +嗜碱性粒细胞。在3例接受环孢霉素治疗的ASST + CU患者中,在治疗前后进行了该测定。与ASST-CU和健康供体血清相比,ASST + CU血清导致嗜碱性粒细胞CD63表达的诱导明显更高。当使用D(A)的全血时,测定的灵敏度和特异性分别为95.5%和90.5%。环孢霉素A治疗期间ASST + CU血清活性明显降低,同时临床缓解。通过我们的三色FCM方法对D(A)全血进行的慢性荨麻疹血清诱导的CD63表达测定可能是鉴定部分自身免疫性CU患者最有用的工具,并且可能成为监测治疗效果的有前途的工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号